However, in our recent in vivo study, we demonstrated a gender-specific correlation between STAT3 expression and KRAS-mutant NSCLC; female mice with tumor-cell-specific STAT3 deletion showed decreased tumorigenesis while males had the opposite outcome [121]. The gene discussed is STAT3; the disease is neoplasm.